1. Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura. Issue 5 (21st May 2018) Authors: Herbrecht, R.; Ojeda‐Uribe, M.; Kientz, D.; Fohrer, C.; Bohbot, A.; Hinschberger, O.; Liu, K.‐L.; Remy, E.; Ernst, C.; Lin, J.‐S.; Corash, L.; Cazenave, J. P. Journal: Vox sanguinis Issue: Volume 113:Issue 5(2018) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗